Date(s)

18 Sep 2024 - 20 Sep 2024

Important dates

Abstract Submission Deadline

Friday, 28 June 2024 at 23:59 CET

Location

Liverpool, United Kingdom

Meeting type

Hybrid Meeting

Submit Abstract

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

General

What's New

The abstract portal of the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 is now open until Friday, 28 June 2024 at 23:59 CEST.
Registration is now open!
It is a pleasure to announce that the confirmed venue for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 is at the following location:

Spaces at The Spine
The Spine Building, 2 Paddington Village,
Liverpool L7 3FA,
United Kingdom
Distance from Manchester Airport (MAN): 50 minutes
To commemorate this special anniversary edition, all accepted abstracts will be published in the British Journal of Clinical Pharmacology!
To stay updated on the latest developments, make sure you are signed up for our newsletter.

Welcome

It is our pleasure to announce that 25th Anniversary Edition of The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 will take place as a hybrid workshop from 18-20 September 2024 in Liverpool, United Kingdom.

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs gathers leading experts to discuss all aspects of the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in underrepresented populations, post-marketing surveillance, and regulatory considerations.

Program Chairs 2024

Kimberly Scarsi, PharmD, MS, FCCP

University of Nebraska Medical Center (UNMC), United States

Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP

Toronto General Hospital, University of Toronto, Canada

General Information

COVID-19 Update

Responding to the changing COVID-19 situation, the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 will be held as a hybrid meeting allowing both in-person and virtual attendance. This workshop format is an optimal solution in light of the current circumstances.

We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Daria Bohdanova via Daria.Bohdanova@amededu.com.

Who Should Attend?

- Clinical pharmacologists;

- Pharmacists;

- Clinicians/ researchers;

- Industry representatives;

- Regulatory scientists;

- Government representatives;

- Post-graduate students; and

- Others involved in the clinical pharmacology of antiviral therapy.

Meeting Objectives

This meeting aims to:

- Gather experts involved in clinical pharmacology from different disciplines in an interactive workshop setting;

- Provide a platform for presentation and discussion of the latest developments in the field;

- Share information on ongoing pharmacological studies; and

- Stimulate discussion and consensus on best practices.

Learning Objectives

After participating in this activity, participants will be able to:

- Outline new developments and the clinical pharmacology of antiviral therapies for HIV, COVID-19, Hepatitis, and other viruses;

- Reflect on new Drug Detection / Delivery Technologies; and

- Describe pharmacological considerations in key populations.

Practical Information

Venue

The Venue for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 will be confirmed shortly.

Accommodation

Accommodation is not included in the registration fee.

Badges

All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.

Certificate of Attendance

A certificate of attendance will be sent to participants after they have successfully completed the program and post-meeting survey.

Language

The official language of the conference/meeting/workshop is English
Translation will/will not be provided.

Disclaimer

This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.

Liability and Insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Registration

Registration is Open!

Fees and Conditions

	Regular Delegates- In-Person	Regular Delegates- Virtual	Industry*** - In-Person	Industry*** - Virtual
Early Fee (payment before/on 5 April 2024)	€495.00	€395.00	€695.00	€595.00
Standard Fee (payment before/on 17 September 2024)	€695.00	€595.00	€895.00	€795.00
Same-Day Fee* (payment from 18 September 2024)	€795.00	€695.00	€995.00	€895.00


Discounts
Early-career investigators /Regular Delegates from Resource-Limited Settings (RLS)** WITH ACCEPTED ABSTRACT	Complimentary Registration
Early-Career Investigators /Regular Delegates from Resource-Limited Settings (RLS)** WITHOUT ACCEPTED ABSTRACT	50% Off Current Regular Delegate Fee
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates	50% Off Current Regular Delegate Fee
Representatives of sponsoring industry / endorsing organizations ***	Please contact the conference secretariat

* To register on the workshop dates and revisit the recordings of the live stream on the virtual portal.

** Countries included in the low-income and lower-middle-income economies of the World Bank Classification.

*** Industry and endorser representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us via Jesper.Niesen@amededu.com

If you have financial concerns or are eligible for a discount, please contact the conference secretariat via Daria.Bohdanova@amededu.com

Important

We strongly advise that you register early to secure your slot.
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full payment has been received (if applicable) and a confirmation of your registration has been sent.

Registration Fee Includes

For onsite attendees:

- Access to all scientific sessions, including poster area

- Conference pack, including abstract book and program

- Refreshments during the coffee breaks

- Buffet lunch on meeting days

For virtual attendees only:

- Access to all scientific sessions

- Digital workshop pack, including the program

IMPORTANT:

- No day rate is available

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.

Group Registration

For registration of groups larger than 5 participants, please contact the Conference Secretariat at Daria.Bohdanova@amededu.com.

Early-Career Investigators / Academia from Resource-limited Settings (RLS)

We are pleased to waive the registration fee for early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract and a 50% discount on the registration fee without an accepted abstract.

IMPORTANT: The fee waiver is offered to the presenting author only.

To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.

Payment

By credit card only: online or by written authorization.

Please contact the conference secretariat via Daria.Bohdanova@amededu.com if you need to make alternative arrangements.

Cancellation Policy

In case of cancellation, the following refunds are applicable:

- Cancellation before/on 12 August 2024: 50% refund (minus an administration fee of €40)
- Cancellation after 12 August 2024: Unfortunately, no refund will be given

Should you be unable to attend the forum, a substitute delegate is always welcome at no extra charge provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 26 August 2024. A statement (email/letter) of your cancellation must be sent to Virology Education.

Liability and Insurance

By registering for the meeting, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.

Media Registration

In order to register as a media participant for the workshop, the conference secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Academic Medical Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2024 embargo policy.

Disclaimer

This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.

Downloads:

AntiviralPK 2024_Early-Career_Application Form.docx

Downloads:

AntiviralPK 2024_RLS Application Form.docx

Program

The program for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 is currently under development and will be announced in due time.

If you would like to view the program for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023, please click here.

Abstracts

Abstract submission portal for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 is now open.

Submit Abstract

Abstracts

The abstract portal of the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 is now open until Friday, 28 June 2024 at 23:59 CET.
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 accepts new original data as well as encored abstracts. All abstracts must contain up-to-date information at the time of the conference.
Registration fees are waived for early-career professionals with an accepted abstract. A 50% discount is offered to early-career professionals without an accepted abstract. The requirements for the application are specified here.
Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here
To commemorate this special anniversary edition, all accepted abstracts will be
published in the British Journal of Clinical Pharmacology!

Categories for Abstract Submission

For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

- Cellular and Tissue Pharmacokinetics
- Drug-Drug Interactions
- Novel Drugs and Formulations
- Pharmacogenetics
- Pharmacokinetics during Pregnancy and Other Key Populations
- PK/PD of Drug Efficacy and Toxicity (including TDM)

General Guidelines

Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language

Abstract Submission

Authors can submit their abstracts electronically until Friday, 28 June 2024 at 23:59 CET. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Committees

Workshop Chairs

Kimberly Scarsi, PharmD, MS, FCCP

University of Nebraska Medical Center (UNMC), United States

Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP

Toronto General Hospital, University of Toronto, Canada

Local Chair

Saye Khoo, MD, PhD

Royal Liverpool University Hospital; University of Liverpool, United Kingdom

Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Peter L. Anderson, PharmD

University of Colorado, Anschutz Medical Campus, United States

Tim Cressey, MSc, PhD

Chiang Mai University, Thailand

Andrew Owen, BSS, MSC, PhD, FSB

University of Liverpool, United Kingdom

Kimberly Scarsi, PharmD, MS, FCCP

University of Nebraska Medical Center (UNMC), United States

Kimberly Struble, PharmD

Food and Drug Administration, United States

Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP

Toronto General Hospital, University of Toronto, Canada

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Vikram Arya, PhD, FCP - Food and Drug Administration, United States
Kristina Brooks, PharmD - University of Colorado Anschutz Medical Campus, United States
Andrea Calcagno, MD, DTM&H - University of Turin, Italy
Su-Young Choi, PharmD, PhD - Food and Drug Administration, United States
Angela Colbers, PhD - Radboud University Medical Center, the Netherlands
Paolo Denti, PhD - University of Cape Town, South Africa
Tanuja N. Gengiah, B.Pharm, MClinPharm, Ms(Epi), PhD - Centre for the AIDS Programme of Research (CAPRISA) & University of KwaZulu-Natal, South Africa
Mohammed Lamorde, MD - Infectious Diseases Institute, Uganda
Minh Patrick Lê, PhD - Hôpital Bichat-Claude Bernard, France
Lawrence Lee, MBBS, PhD - National University of Singapore, Singapore
Catia Marzolini, PharmD, PhD - University Hospital Basel, Switzerland & University of Liverpool, United Kingdom
Steve Taylor, MRCP, PhD - Birmingham Heartlands Hospital, United Kingdom
Catriona Waitt, MBChB, PhD - University of Liverpool, United Kingdom
Julie Dumond, Pharm.D., M.S. - UNC Eshelman School of Pharmacy,United States

Academic Advisory Board

The members of the Academic Advisory Board (AAB) are former members of the OC and remain active the in planning of the program for the next year. Members of the current OC are selected from this group.

David Back, PhD - University of Liverpool, United Kingdom
Terrence Blaschke, MD - Stanford University School of Medicine, United States
Marta Boffito, MD, PhD, FRCP - Chelsea and Westminster Hospital London, United Kingdom
David Burger, MD, PhD - Radboud University Medical Center, the Netherlands
Giovanni Di Perri, MD, PhD - University of Torino, Italy
Courtney Fletcher, PharmD - University of Nebraska Medical Center, United States
Charles Flexner, MD - Johns Hopkins University, United States
Angela Kashuba, PharmD - University of North Carolina at Chapel Hill, United States
Jürgen Rockstroh, MD - University of Bonn, Germany
Jonathan Schapiro, MD - National Hemophilia Center, Sheba Medical Center, Israel

Industry Liaison Board

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

Wei Liu - AbbVie
Thomas Kakuda - Alios BioPharma
Xiao-Jian Zhou - Atea Pharmaceuticals
Simon Portsmouth - Shionogi

Support

Gold Level

Support provided by ViiV Healthcare.

Silver Level

Supported by Gilead who provided funding. Gilead has had no input into the content of the materials used at this meeting/conference.

Support Our Initiative

Financial backing to the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in clinical pharmacology of HIV, Hepatitis, and other antiviral drugs.

This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored support package by contacting Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 230 7140.

Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

Symposium opportunities
Non-commercial interviews with company representatives
Verbal acknowledgement during the program
Discounted and complimentary registrations for your representatives
Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
Company acknowledgement on printed meeting materials including but not limited to banners and the program book
Digital and printed advertising opportunities
Social media shout-outs
Logo on the conference bag

*Subject to the support level.

Endorsers

Venue

The confirmed venue details for the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 can be found below.

Venue: Spaces at The Spine
Website: https://spacesatthespine.co.uk/
Address: The Spine Building, 2 Paddington Village, Liverpool L7 3FA, United Kingdom (please click here to view the map).
Distance from Manchester Airport (MAN): 50 minutes

In case you have any questions or concerns regarding the venue, please feel free to contact us at Dominika.balounova@amededu.com.

Accommodation

We look forward to welcoming you to Liverpool!

As you plan your trip to Liverpool, we want to make your stay as comfortable and convenient as possible. Therefore, we are working hard to secure a list of appropriate hotels with beneficial rates in the area that you can reach out to below. We will provide the information on the hotels here once we have the information available.

The main partner hotel, Novotel Liverpool Paddington Village, is directly adjacent to the venue and provides you with the ultimate comfort. Apart from the main hotel we have secured other hotels in the area that will provide you with a beneficial rate

If you are interested in booking your stay in one of our partners hotel below, please reach out to u.s at Dominika.balounova@amededu.com to receive a discount code that you can include in your reservation.

Should you also be interested in having your accommodation arranged by the Organizers directly, please do not hesitate to reach out to us at Dominika.balounova@amededu.com . We will be happy to assist you further, depending on the availability of the hotels.

Main Partner Hotel - Booking Link